Connect with us

Uncategorized

Actress Michelle Pfeiffer Recalls Inappropriate Incident in Hollywood

Published

on

Maleficent: Mistress Of Evil actress Michelle Pfeiffer says she once had an “inappropriate incident” with a “high-powered” man from the film industry.

The 61-year-old recalled the incident in an interview to The Sunday Times Magazine, without naming the person involved. She said that looking back on the experience makes her “cringe”, reports independent.co.uk. The #MeToo movement prompted her to re-evaluate her past, she said.

“First, I thought, ‘Well, I didn’t experience that’, but then as time went on I started going, ‘Well, actually, there was that one time’,” the actress said.

Explaining the “process” she went through, the star said she had denied the incident and blamed herself for it, having thoughts like “I shouldn’t have worn that dress” or “I should’ve known”.

“There were a number of situations that were not good. Like one incident — I am not going to share — but I look back and I cringe. I was really uncomfortable and it was inappropriate. I put it in a drawer. I was 20, and it was with a high-powered person in the industry,” she said. Michelle Pfeiffer added that if the man in question was still alive, she would write to him. Pfeiffer’s comments come after a spate of similar allegations from stars, including Naomie Harris and Sarah Jessica Parker, who revealed that she had reported a “big movie star” for “inappropriate behaviour” on set when she was a young actor.

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

*

code

Uncategorized

Selena Gomez will mark her first televised performance in two years.

Published

on

Selena Gomez will take the stage to perform at the 2019 American Music Awards.

The awards show will mark Gomez’s first televised performance in two years. Her past performances at the AMAs were in 2014, 2015 and 2017, where she performed her hit “Wolves.”

The singer has previously been nominated for two AMAs, while she took home the favorite pop/rock female artist award in 2016.

It’s been four years since she released 2015’s Revival, which remains her most recent album. She debuted the ballad “Lose You to Love Me” in late October, kicking off the promotion for her yet-to-be-titled upcoming album. “Lose You to Love Me” followed 2018’s “Back to You” for Netflix’s 13 Reasons Why soundtrack and her early 2019 collaboration with Benny Blanco titled “I Can’t Get Enough.”

Shortly following the release of “Lose You to Love Me,” Gomez dropped a second song from the upcoming album called “Look At Her Now.”

It was previously announced that Taylor Swift will also perform at the awards show. In addition to accepting the artist of the decade award, Swift will deliver a performance to celebrate the biggest hits of her 13-year career.

To mark the end of the decade, the 2019 AMAs will celebrate the past 10 years of music by highlighting some of the most memorable moments and live performances from big names in the industry.

Post Malone is the most performer of the night with seven total nods, while Ariana Grande and Billie Eilish follow close behind with six nominations each. Swift and Lil Nas X are both up for five awards, while Billy Ray Cyrus, Khalid and Ella Mai all earned four nods.

The 2019 American Music Awards will be broadcast live on ABC from the Microsoft Theater in Los Angeles on Sunday, Nov. 24.

Continue Reading

News & Entertainment

Hollywood actress Kim Kardashian surprised when her husband gave a unique gift

Published

on

In the past, American model and actress Kim Kardashian has celebrated her birthday. Kim’s husband gave such a gift on her birthday which she was surprised to see. Kanye West gave something that Kim had never even imagined in her dream.

According to media reports, Kanye donated one million dollars to four charities. Just because Kim supports that charity. Kim also shared this news with her fans. She wrote – “My heart is happy. I got very good gifts”.

Kim had recently revealed that she has been experiencing problems like pain, swelling in the joints, headache, a weakness for several days. Her rheumatoid arthritis and autoimmune disease have turned out to test positive for lupus. In autoimmune disease, the immune system starts targeting healthy cells. Kim made headlines this year for her dress at the Met Gala. During this time, Kim was wearing a Transparent which caused water droplets to drip. It seemed as if Kim had reached the Met Gala by taking a bath from the sea.

Continue Reading

Politics

Key House committee passes Speaker Nancy Pelosi’s sweeping drug pricing bill

Published

on

The House Energy and Commerce Committee on Thursday approved Speaker Nancy Pelosi‘s sweeping drug pricing bill, a key step in getting the legislation to the full House floor for a vote later this year.

The bill passed on a vote of 30 to 22 on Thursday evening.

The main thrust of Pelosi’s bill will allow Medicare to negotiate lower prices on as many as 250 of the most expensive drugs per year and apply those discounts to private health plans across the U.S. The bill also includes a penalty on drug makers that refuse to negotiate or fail to reach an agreement with the U.S. government, starting at 65% of the gross sales of the drug in question.

Republican members on the committee expressed concerns with the legislation, particularly that it would discourage innovation for new medicines in the pharmaceutical industry. Some GOP members said the legislation was rushed and dead on arrival in the Senate.

“I don’t believe that I was elected to write bills that would never go anywhere,” said Michael Burgess of Texas, the top Republican on the Energy and Commerce Committee’s health panel. “And that’s exactly where this bill is headed.”

Prior to the vote Thursday, Energy and Commerce Chairman Frank Pallone Jr, D-NJ, introduced changes to the bill, which included a price cap for new negotiated drugs until there are at least two or more generic competitors. It also increases the minimum number of drugs Medicare must negotiate from 25 to 35, which would be phased in.

The legislation will need to move through other committees before it can go to the full House floor for a vote. Pelosi and other House Democratic leaders, who had been working on the plan for months, are working to get it through committees to the floor as soon as the end of this month. The House Education and Labor Committee approved the bill Thursday on a party-line vote.

Late Friday, a preliminary analysis from the nonpartisan Congressional Budget Office showed Pelosi’s plan would save Medicare $345 billion over 10 years. Those savings wouldn’t begin until 2023, assuming the bill gets passed by both the House and Senate and signed by Trump before the end of this year. The greatest savings would come in 2028 at $93 billion, the CBO said.

High prescription drug costs have become a rare bipartisan issue, with lawmakers on both sides of the aisle demanding changes. Congress and the Trump administration are trying to pass legislation before the end of the year that would bring more transparency to health-care costs and, ultimately, lower costs for consumers. Health care remains a top issue for voters ahead of the 2020 presidential election.

Senate Finance Committee Chairman Chuck Grassley, R-Iowa is also currently working to rally support for a Senate drug pricing bill backed by Trump.

That plan, which lawmakers have described as a “middle ground” approach to handling drug prices, would also make changes to Medicare and includes a penalty for pharmaceutical companies that raise drug prices faster than inflation.

The Pharmaceutical Research and Manufacturers of America, called PhRMA, the industry’s main trade group, opposes both Pelosi’s and Grassley’s plans. The group says Pelosi’s bill gives “the federal government unprecedented, sweeping authority to set medicine prices in public and private markets while importing price controls from other countries that restrict access to innovative medicines.”

Continue Reading

Trending

Pin It on Pinterest

Share This